Lawson Health Research Institute, St. Joseph's

London, Ontario N6A 4V2

0 studies enrolling now · 2 studies all time

What they study most

Frontotemporal Dementia, Healthy

Studies at this site

• A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2) — Completed
• A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation — Completed